中国全科医学2017，Vol.20Issue(8)：891-895,5.DOI:10.3969/j.issn.1007-9572.2017.08.001
2016年《美国内分泌医师协会与美国内分泌协会绝经后骨质疏松症诊疗指南》解读
Interpretation of American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2016
摘要
Abstract
The prevalence of osteoporosis is growing rapidly with the aging of the population.Osteoporosis leads to decrease of physical function and quality of life.Moreover,fracture due to osteoporosis can bring about increased disability rate and mortality,and a great burden on family and society.Thankfully,anti-osteoporotic treatment is able to decrease fractures,and subsequent fractures effectively among those who already suffer from fractures.From the aspects of fracture risk assessment and osteoporosis diagnosis,basic intervention and pharmacological intervention,this article briefly interpreted the updated Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis jointly issued by American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) in 2016,aiming to keep clinicians informed of the recent developments in osteoporosis diagnosis and treatment by which their clinical practice can be improved.关键词
骨质疏松,绝经后/指南/骨折/治疗Key words
Osteoporosis/postmenopausal/Guidelines/Fractures/bone/Therapy分类
医药卫生引用本文复制引用
李静,陈德才,王覃..2016年《美国内分泌医师协会与美国内分泌协会绝经后骨质疏松症诊疗指南》解读[J].中国全科医学,2017,20(8):891-895,5.基金项目
四川省科技计划资助项目(2015JY0180) （2015JY0180）
